Alembic Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ALEMBICLTD.BO | APLLTD.BO | IOLCP.NS | INDOCO.NS | AARTIDRUGS.BO | IAM | |
|---|---|---|---|---|---|---|
| Market cap | 23.62B | 154.92B | 51.14B | 21.34B | 35.59B | 731.16M |
| P/E (TTM) | 7.3 | 22.3 | 30.5 | 723.4 | 18.6 | — |
| Forward P/E | — | 16.1 | 16.8 | 19.1 | 14.0 | — |
| Price/book | 0.9 | 2.7 | 2.8 | 2.1 | 2.3 | -1.6 |
| Dividend yield | 2.49% | 1.52% | 0.55% | 0.08% | 0.50% | — |
| 1-year change | −17.33% | −15.06% | +92.46% | −16.19% | −21.36% | −15.34% |
| Today | −3.31% | −0.26% | −4.85% | −2.11% | −2.29% | −3.65% |
The closest companies by business and industry (Real Estate - Development). Prices may be delayed up to 15 min.
Latest news
All ALEMBICLTD.BO news ›Alembic Pharma gets USFDA nod for generic ear infection drug
New Delhi, Oct 19 (PTI) Alembic Pharmaceuticals Ltd on Monday said it has received the final approval from the US Food and Drug Administration (USFDA) for its generic Ciprofloxacin and Dexamethasone Otic Suspension USP. The product is…
Alembic Pharmaceuticals: Gets USFDA Approval for Otic Suspension
InvestyWise delivers real-time Indian stock market news, corporate filings, regulatory disclosures, and financial analysis. Track NSE and BSE-listed companies with AI-powered insights for smarter investment decisions. Alembic…
Alembic Pharmaceuticals Ltd receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%.
Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ciprofloxacin and Dexamethasone Otic Suspension USP,…
Alembic Therapeutics LLC Announces Availability of Clonidine Hydrochloride Tablets, 0.05mg
BioSpace Alembic Therapeutics LLC Announces Availability of Clonidine Hydrochloride Tablets, 0.05mg BEDMINSTER, N.J., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC announces the launch of Clonidine Hydrochloride Tablets,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
equitybulls.com1
-
investywise.com1
-
news18.com1
-
sahi.com1
-
scanx.trade1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.